SCHEMBL11031370

SCHEMBL11031370

CC(O)[C@H](O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29888723 1.00
SCHEMBL14948561 1.00
SCHEMBL9765967 1.00
SCHEMBL1926252 1.00
SCHEMBL50023 1.00
Ethane SCHEMBL16390773 0.96
Ammonia Solution, Strong SCHEMBL9545199 0.96
Methoxymethane SCHEMBL2230632 0.90 TDP1 (0.44)
Glycerin SCHEMBL27514435 0.90 LMNA (0.56)
Bicarbonate SCHEMBL29012506 0.87 PDE4A (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3085727-B1 SILICONE AND USE THEREOF SHINETSU CHEMICAL CO (JP) 2017-06-21 EP disclosed
US-20170002382-A1 MICROBIAL ENGINEERING FOR THE PRODUCTION OF CHEMICAL AND PHARMACEUTICAL PRODUCTS FROM THE ISOPRENOID PATHWAY MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2017-01-05 US disclosed
EP-2216407-B1 Therapeutic compositions ALNYLAM PHARMACEUTICALS INC (US) 2016-01-13 EP disclosed
US-20120190861-A1 Levodopa Prodrugs, and Compositions and Uses Thereof XENOPORT, INC. (US) 2012-07-26 US disclosed